323 related articles for article (PubMed ID: 32731612)
1. Current Trends in ATRA Delivery for Cancer Therapy.
Giuli MV; Hanieh PN; Giuliani E; Rinaldi F; Marianecci C; Screpanti I; Checquolo S; Carafa M
Pharmaceutics; 2020 Jul; 12(8):. PubMed ID: 32731612
[TBL] [Abstract][Full Text] [Related]
2. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
3. Acute promyelocytic leukemia and differentiation therapy: molecular mechanisms of differentiation, retinoic acid resistance and novel treatments.
Özpolat B
Turk J Haematol; 2009 Jun; 26(2):47-61. PubMed ID: 27265273
[TBL] [Abstract][Full Text] [Related]
4. The success and the challenge of all-trans retinoic acid in the treatment of cancer.
Ni X; Hu G; Cai X
Crit Rev Food Sci Nutr; 2019; 59(sup1):S71-S80. PubMed ID: 30277803
[TBL] [Abstract][Full Text] [Related]
5. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
6. All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells.
Liu X; Chen J; Yu S; Yan L; Guo H; Dai J; Zhang W; Zhu J
Cell Death Dis; 2017 May; 8(5):e2782. PubMed ID: 28492552
[TBL] [Abstract][Full Text] [Related]
7. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells.
Lee KH; Chang MY; Ahn JI; Yu DH; Jung SS; Choi JH; Noh YH; Lee YS; Ahn MJ
Biochem Biophys Res Commun; 2002 Sep; 296(5):1125-33. PubMed ID: 12207890
[TBL] [Abstract][Full Text] [Related]
8. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
9. [Research Advances on Mechanisms of Resistance to All-Trans Retinoic Acid in Acute Promyelocytic Leukemia--Review].
Niu YN; Liu WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):2024-2029. PubMed ID: 31839078
[TBL] [Abstract][Full Text] [Related]
10. Designed ATRA analogue active against ATRA-resistant acute promyelocytic leukemia cells having a single nucleotide substitution in their retinoic acid receptor.
Komura N; Ikeda Y; Masuda N; Umezawa Y; Ito K; Kizaki M; Umezawa K
Leuk Res; 2007 Mar; 31(3):301-13. PubMed ID: 16968653
[TBL] [Abstract][Full Text] [Related]
11. RACK1 deficiency synergizes with all-trans retinoic acid to induce apoptosis in human acute promyelocytic leukemia cells.
Wu H; Liu J; Huang X; Pian L; Cheng Q; Wang Q; Zhao M; Lin Z; Shen B; Zhang J; Li S; Wang J
Mol Cell Biochem; 2019 Jan; 451(1-2):155-163. PubMed ID: 30019299
[TBL] [Abstract][Full Text] [Related]
12. New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation.
Kitamura K; Kiyoi H; Yoshida H; Tobita T; Takeshita A; Ohno R; Naoe T
Cancer Chemother Pharmacol; 1997; 40 Suppl():S36-41. PubMed ID: 9272132
[TBL] [Abstract][Full Text] [Related]
13. Liposomal-all-trans-retinoic acid in treatment of acute promyelocytic leukemia.
Ozpolat B; Lopez-Berestein G
Leuk Lymphoma; 2002 May; 43(5):933-41. PubMed ID: 12148903
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
[TBL] [Abstract][Full Text] [Related]
15. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
Leukemia; 1994; 8 Suppl 2():S16-9. PubMed ID: 7815831
[TBL] [Abstract][Full Text] [Related]
16. miR-382-5p modulates the ATRA-induced differentiation of acute promyelocytic leukemia by targeting tumor suppressor PTEN.
Liu D; Zhong L; Yuan Z; Yao J; Zhong P; Liu J; Yao S; Zhao Y; Liu L; Chen M; Li L; Liu B
Cell Signal; 2019 Feb; 54():1-9. PubMed ID: 30453015
[TBL] [Abstract][Full Text] [Related]
17. Primaquine phosphate induces the apoptosis of ATRA-resistant acute promyelocytic leukemia cells by inhibition of the NF-κB pathway.
Ma L; Chen L; Li H; Ge L; Wang S; Zhang Z; Huang H; Shi L; Li T; Gu H; Lyu J; He L
J Leukoc Biol; 2020 Apr; 107(4):685-693. PubMed ID: 32125014
[TBL] [Abstract][Full Text] [Related]
18. All-trans retinoic acid regulates adhesion mechanism and transmigration of the acute promyelocytic leukaemia cell line NB-4 under physiologic flow.
Brown DC; Tsuji H; Larson RS
Br J Haematol; 1999 Oct; 107(1):86-98. PubMed ID: 10520028
[TBL] [Abstract][Full Text] [Related]
19. All trans retinoic acid and cancer.
Siddikuzzaman ; Guruvayoorappan C; Berlin Grace VM
Immunopharmacol Immunotoxicol; 2011 Jun; 33(2):241-9. PubMed ID: 20929432
[TBL] [Abstract][Full Text] [Related]
20. Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers.
Lavudi K; Nuguri SM; Olverson Z; Dhanabalan AK; Patnaik S; Kokkanti RR
Front Cell Dev Biol; 2023; 11():1254612. PubMed ID: 37645246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
